Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma
Clinical trial NCT05042934 · WITHDRAWN
Trial details
- NCT number
- NCT05042934
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-15
- Primary completion
- 2022-08-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.